<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR107">
 <label>107.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Scharton</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Bailey</surname>
    <given-names>KW</given-names>
   </name>
   <name>
    <surname>Vest</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Westover</surname>
    <given-names>JB</given-names>
   </name>
   <name>
    <surname>Kumaki</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Van Wettere</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment</article-title>
  <source>Antiviral Res</source>
  <year>2014</year>
  <volume>104</volume>
  <fpage>84</fpage>
  <lpage>92</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2014.01.016</pub-id>
  <?supplied-pmid 24486952?>
  <pub-id pub-id-type="pmid">24486952</pub-id>
 </element-citation>
</ref>
